Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials.

Authors:
Yang Z; Li J; Zhou B; Ji X; Yuan J and 3 more

Journal:
Chin Med

Publication Year: 2023

DOI:
10.1186/s13020-023-00866-x

PMCID:
PMC10717272

PMID:
38093294

Journal Information

Full Title: Chin Med

Abbreviation: Chin Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This research was funded by TCM research Project of Heilongjiang Province (ZHY2020-148), TCM research Project of Heilongjiang Province (ZHY2023-174) and Applied Technology Research and Development Project of Science and Technology Bureau of Harbin, Heilongjiang Province (2017RAQXJ208)."

Evidence found in paper:

"The present study was reported in strict accordance with the reporting standards outlined in the PRISMA extension statement [] and has been registered with PROSPERO, with registration number being CRD42023411553."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025